No Data
Huaxia Ophthalmology (301267.SZ): Actively laying out Asia Vets Medical Services and exploring intelligent transformation.
On March 12, Glonghui reported that Huaxia Ophthalmology (301267.SZ) stated on the investor interaction platform that it always focuses on patient needs, driven by Technology innovation, actively layouts smart Medical Services, and explores intelligent transformation. This strategic cooperation agreement signed with Hive Technology will fully integrate SSE Select Resources Industries Index, in aspects of technology research and development, data sharing, and application landing, to carry out in-depth cooperation and further explore the application potential of smart glasses in the field of Ophthalmology Medical Services, continuously providing patients with high-quality, cutting-edge Ophthalmology diagnosis and treatment services.
Cautious Investors Not Rewarding Huaxia Eye Hospital Group Co.,Ltd.'s (SZSE:301267) Performance Completely
Huaxia Ophthalmology (301267.SZ): AI technology has been applied in aspects such as eye disease screening, diagnosis, personalized treatment, and Asia Vets.
On February 20, in a statement on the investor interaction platform, Huaxia Eye Hospital (301267.SZ) mentioned that in recent years, the company has been actively promoting the application of Big Data, AI, and other new generation information technologies to accelerate the construction of an intelligent Medical system and continuously improve the level of diagnosis and treatment services. Currently, the company has applied AI technology in various Business aspects such as eye disease screening, diagnosis, personalized treatment, and intelligent customer service, and has successively built several intelligent Medical platforms, including the Eye Care Smart Diagnosis and Treatment Service Platform 3.0, Xiamen Eye 5G Remote Diagnosis and Treatment Smart Medical Platform, and the Diabetes Retinopathy Screening Multimodal Imaging AI Internet Hospital Platform, and has started.
Huaxia Eye Hospital Group Co.,Ltd.'s (SZSE:301267) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Huaxia Eye Hospital (301267.SZ): The company's proportion of Medicare income is not high.
On January 15, Gelonghui reported that Huaxia Eye Hospital (301267.SZ) indicated during an investor relations activity that the proportion of the company's medical insurance income is not high, and the settlement situation of the medical insurance Fund is similar to previous years, with no significant changes.
Huaxia Ophthalmology (301267.SZ): The surgical structure of the refractive Business will remain stable overall in 2024.
On January 15, Gelonghui reported that Huaxia Eye Hospital (301267.SZ) stated during an investor relations activity that in 2024, the structure of the refractive Business remained stable overall, with no significant changes in the proportions of various sub-surgical procedures.
Returns On Capital At Huaxia Eye Hospital GroupLtd (SZSE:301267) Have Hit The Brakes